Retraction

Aberrant methylation of Reprimo in lung cancer

Paper Information

Record ID:
4334
Author(s):
Makoto Suzuki
Hisayuki Shigematsu
Takao Takahashi
Narayan Shivapurkar
Ubaradka G Sathyanarayana
Toshihiko Iizasa
Takehiko Fujisawa
Adi F Gazdar
Journal:
Lung Cancer: Journal of the International Association for the Study of Lung Cancer ( Elsevier )
Publication Date:
March 01, 2005
Retraction Date:
August 01, 2014 (11.3 years years ago)
Subjects:
Broad Categories:
Microbiology Biology Genetics
Institution:
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593, USA Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8607, Japan
Countries:
🇯🇵 Japan 🇺🇸 United States
Article Type:
Research Article
Publisher:
Elsevier
Open Access:
Yes
DOI:
10.1016/j.lungcan.2004.08.006
PubMed ID:
15713514
Retraction PubMed ID:
25152943

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1016/j.lungcan.2014.05.004

Citations (25)

25
Total Citations
1
Post-Retraction
(4.0%)
17
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
1308 Days since retraction (latest)
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Mar 2018
1308 days after retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Dec 2012
608 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Aug 2012
710 days before retraction
Paper citing Methylation of Apoptosis Related Genes in the Path...
Unknown Authors
Unknown Journal
Published: May 2012
819 days before retraction
The p53 circuit board
Kelly D. Sullivan, Corrie L. Gallant‐Behm, Ryan E. Henry et al. (5 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Open Access
Published: Feb 2012
92 citations
906 days before retraction
Paper citing Methylation of Apoptosis Related Genes in the Path...
Unknown Authors
Unknown Journal
Published: Oct 2010
1387 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Jun 2010
1497 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Oct 2009
1750 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: May 2009
1907 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Jan 2009
2038 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Oct 2008
2101 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Jul 2007
2588 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Dec 2006
2772 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Nov 2006
2816 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Oct 2006
2861 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Oct 2005
3226 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Jul 2005
3294 days before retraction
Paper citing Aberrant methylation of Reprimo in lung cancer...
Unknown Authors
Unknown Journal
Published: Apr 2005
3392 days before retraction
Quick Stats
Total Citations: 25
Years Since Retraction: 11.3 years
Open Access: Yes
Last Checked: Never
Related Papers
Antitumor activity of bortezomib in human cancer cells with…
Lung Cancer: Journal of the International Association for the Study of Lung Cancer • 32 citations
Protein kinase CK2 phosphorylation regulates the interactio…
Nucleic Acids Research • 41 citations
Protein kinase CK2 phosphorylation regulates the interactio…
Nucleic Acids Research • 41 citations
Systematic editing of synthetic RIG-I ligands to produce ef…
Nucleic Acids Research • 5 citations
MicroRNA-218 increases cellular sensitivity to Rapamycin vi…
APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica • 9 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice